🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/12/2006 | 40,80 | 41,17 | 40,42 | 40,87 | -0,18% | 1,83% | 85.280 |
| 05/12/2006 | 40,39 | 41,17 | 40,12 | 40,95 | +1,30% | 2,59% | 154.877 |
| 04/12/2006 | 40,35 | 40,65 | 39,98 | 40,42 | +0,09% | 1,67% | 95.993 |
| 01/12/2006 | 40,31 | 40,65 | 39,68 | 40,39 | +0,65% | 2,41% | 79.028 |
| 30/11/2006 | 40,24 | 41,17 | 39,83 | 40,12 | -1,02% | 3,35% | 227.038 |
| 29/11/2006 | 40,87 | 41,25 | 40,16 | 40,54 | -0,37% | 2,66% | 282.128 |
| 28/11/2006 | 40,99 | 40,99 | 40,39 | 40,69 | -0,73% | 1,46% | 147.102 |
| 27/11/2006 | 41,62 | 42,03 | 40,57 | 40,99 | -1,97% | 3,51% | 230.992 |
| 24/11/2006 | 41,92 | 42,30 | 41,58 | 41,81 | -1,06% | 1,70% | 9.110 |
| 22/11/2006 | 42,03 | 42,48 | 41,21 | 42,26 | +0,36% | 3,03% | 202.432 |
| 21/11/2006 | 42,26 | 42,48 | 41,96 | 42,11 | -0,71% | 1,24% | 56.586 |
| 20/11/2006 | 42,71 | 43,31 | 42,37 | 42,41 | -0,70% | 2,19% | 120.973 |
| 17/11/2006 | 42,18 | 43,49 | 41,96 | 42,71 | +0,79% | 3,64% | 296.876 |
| 16/11/2006 | 43,94 | 43,94 | 42,03 | 42,37 | -3,58% | 4,34% | 266.793 |
| 15/11/2006 | 41,51 | 43,94 | 41,29 | 43,94 | +4,82% | 6,40% | 199.012 |
| 14/11/2006 | 41,62 | 42,15 | 40,99 | 41,92 | +0,18% | 2,79% | 114.989 |
| 13/11/2006 | 40,91 | 41,85 | 40,91 | 41,85 | +1,91% | 2,29% | 176.383 |
| 10/11/2006 | 41,14 | 41,17 | 40,80 | 41,06 | -0,90% | 0,91% | 99.573 |
| 09/11/2006 | 42,22 | 42,60 | 41,14 | 41,43 | -2,04% | 3,46% | 203.287 |
| 08/11/2006 | 41,73 | 42,63 | 41,58 | 42,30 | +0,98% | 2,51% | 61.903 |
| 07/11/2006 | 41,40 | 42,33 | 41,36 | 41,88 | +1,27% | 2,35% | 108.390 |
| 06/11/2006 | 41,25 | 41,73 | 40,50 | 41,36 | +0,27% | 2,99% | 127.332 |
| 03/11/2006 | 40,91 | 41,29 | 40,76 | 41,25 | +0,82% | 1,28% | 106.706 |
| 02/11/2006 | 40,39 | 41,21 | 39,68 | 40,91 | +0,55% | 3,80% | 79.589 |
| 01/11/2006 | 41,17 | 41,51 | 39,94 | 40,69 | -0,91% | 3,82% | 86.829 |
| 31/10/2006 | 40,46 | 41,88 | 40,24 | 41,06 | +1,20% | 4,07% | 125.408 |
| 30/10/2006 | 40,80 | 41,14 | 40,27 | 40,57 | -0,55% | 2,11% | 109.832 |
| 27/10/2006 | 40,61 | 42,26 | 40,61 | 40,80 | -0,46% | 4,06% | 187.872 |
| 26/10/2006 | 41,25 | 41,25 | 39,83 | 40,99 | -3,18% | 3,45% | 348.866 |
| 25/10/2006 | 43,53 | 43,79 | 41,96 | 42,33 | -3,08% | 4,21% | 113.786 |